Dark | Light
# Arcus Biosciences, Inc. (RCUS)

RCUS faces headwinds as STAR-221 study is discontinued and TIGIT therapy efficacy concerns rise. Analyst downgrades also contribute to negative price action.

### About Arcus Biosciences, Inc.
Arcus Biosciences, Inc. is a biotechnology company focused on developing novel cancer immunotherapies.  
Arcus Biosciences, Inc. uses the ticker $RCUS for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Arcus Biosciences, Inc. (RCUS) trading volume is up 24.33% from the previous week.
- Arcus Biosciences, Inc. (RCUS) social dominance is up 2125% from the previous week.
- Arcus Biosciences, Inc. (RCUS) sentiment is up 100% from the previous week.
- Arcus Biosciences, Inc. (RCUS) posts created is up 116.67% from the previous week.

### Price: $18.90
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$rcus/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$rcus/time-series/close.tsv)  
The current price action for RCUS is negative, with a significant drop attributed to the discontinuation of the Phase [--] STAR-221 study and broader concerns about TIGIT therapy efficacy, despite a recent 52-week high and some analyst upgrades.  

24-Hour: -5.21%
7-Day: -10.03%
30-Day: -13.21%

1-Year High: $26.10 on 2025-11-28  
1-Year Low: $6.90 on 2025-04-04  
  
  
### AltRank: [-----]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$rcus/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$rcus/time-series/alt_rank.tsv)  
Arcus Biosciences, Inc. (RCUS) is currently AltRank #1,154 based on combined combined social and market metrics
Daily Average: [-----]  
[--] Week: [-----] +1,184  
[--] Month: [-----] +505  
[--] Months: [-----] +742  
[--] Year: [-----] +1,020  
1-Year High: [-----] on 2026-02-06  
1-Year Low: [--] on 2025-12-28  
  
  
### Galaxy Score: [--]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$rcus/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$rcus/time-series/galaxy_score.tsv)  
Current Value: [--]  
Daily Average: [--]  
[--] Week: [--] [---]  
[--] Month: [--] [---]  
1-Year High: [--] on 2026-01-13  
1-Year Low: [--] on 2026-01-16  
  
  
### Engagements: [-----] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$rcus/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$rcus/time-series/interactions.tsv)  
Current Value: [-----]  
Daily Average: [-----]  
[--] Week: [-----] -74%  
[--] Month: [------] +19%  
[--] Months: [-------] +57%  
[--] Year: [-------] -4.50%  
1-Year High: [------] on 2025-11-25  
1-Year Low: [--] on 2025-09-14  

Engagements by network (24h):
News: [--]
Reddit: [--]
TikTok: [--]
X: [---]
YouTube: [--]

  
  
### Mentions: [--] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$rcus/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$rcus/time-series/posts_active.tsv)  
Current Value: [--]  
Daily Average: [--]  
[--] Week: [--] +9.10%  
[--] Month: [---] +76%  
[--] Months: [-----] +23%  
[--] Year: [-----] +172%  
1-Year High: [---] on 2025-06-28  
1-Year Low: [--] on 2025-09-14  

Mentions by network (24h):
News: [--]
Reddit: [--]
TikTok: [--]
X: [--]
YouTube: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$rcus/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$rcus/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning Arcus Biosciences, Inc. (RCUS) in the last [--] hours which is up 29% from [--] in the previous [--] hours
Daily Average: [--]  
[--] Week: [--] +9.40%  
[--] Month: [---] +31%  
[--] Months: [---] -38%  
[--] Year: [-----] +201%  
1-Year High: [---] on 2025-06-28  
1-Year Low: [--] on 2025-09-14  
  
  
### Sentiment: 75%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$rcus/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$rcus/time-series/sentiment.tsv)  
Current Value: 75%  
Daily Average: 75%  
[--] Week: 100% +50%  
[--] Month: 50% +22%  
[--] Months: 50% -38%  
[--] Year: 50% -50%  
1-Year High: 100% on 2025-02-15  
1-Year Low: 3% on 2025-12-07  

Most Supportive Themes:
- Positive Social Media Trends: (75%) Social dominance, Galaxy Score, and sentiment have all seen significant increases, indicating growing positive attention and engagement.
- Increased Content Creation: (25%) The number of posts about Arcus Biosciences has risen over the past [--] months and [--] year, suggesting sustained interest.
  
Most Critical Themes:
- Discontinuation of STAR-221 Study: (60%) The Phase [--] STAR-221 study has been discontinued, raising concerns about TIGIT therapy efficacy.
- Analyst Downgrades: (40%) Arcus Biosciences (RCUS) was among the stocks that received downgrades on February 12th, contributing to negative price action.
  
  
  
### Social Dominance: 0.00225%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$rcus/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$rcus/time-series/social_dominance.tsv)  
Current Value: 0.00225%  
Daily Average: 0.00474%  
[--] Week: 0.0089% +0.0085%  
[--] Month: 0.0031% -0.0012%  
[--] Months: 0.0031% -0.0056%  
[--] Year: 0.0031% -0.001%  
1-Year High: 0.032% on 2025-06-28  
1-Year Low: 0.0002% on 2025-09-14  
  
  
### Market Dominance: 0.00265%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$rcus/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$rcus/time-series/market_dominance.tsv)  
Current Value: 0.00265%  
Daily Average: 0%  
1-Year High: 0.12% on 2026-02-06  
1-Year Low: 0.00265% on 2026-02-14  
  
  
### Market Cap: $2,340,943,901
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$rcus/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$rcus/time-series/market_cap.tsv)  
Current Value: $2,340,943,901  
Daily Average: $2,795,082,619  
[--] Week: $2,338,469,330 -10%  
[--] Month: $2,340,943,901 -13%  
1-Year High: $3,229,314,790 on 2025-11-28  
1-Year Low: $2,340,943,901 on 2026-02-13

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

Arcus Biosciences, Inc. (RCUS)

RCUS faces headwinds as STAR-221 study is discontinued and TIGIT therapy efficacy concerns rise. Analyst downgrades also contribute to negative price action.

About Arcus Biosciences, Inc.

Arcus Biosciences, Inc. is a biotechnology company focused on developing novel cancer immunotherapies.
Arcus Biosciences, Inc. uses the ticker $RCUS for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

  • Arcus Biosciences, Inc. (RCUS) trading volume is up 24.33% from the previous week.
  • Arcus Biosciences, Inc. (RCUS) social dominance is up 2125% from the previous week.
  • Arcus Biosciences, Inc. (RCUS) sentiment is up 100% from the previous week.
  • Arcus Biosciences, Inc. (RCUS) posts created is up 116.67% from the previous week.

Price: $18.90

Price Line Chart
Price 24-Hour Time-Series Raw Data
The current price action for RCUS is negative, with a significant drop attributed to the discontinuation of the Phase [--] STAR-221 study and broader concerns about TIGIT therapy efficacy, despite a recent 52-week high and some analyst upgrades.

24-Hour: -5.21% 7-Day: -10.03% 30-Day: -13.21%

1-Year High: $26.10 on 2025-11-28
1-Year Low: $6.90 on 2025-04-04

AltRank: [-----]

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Arcus Biosciences, Inc. (RCUS) is currently AltRank #1,154 based on combined combined social and market metrics Daily Average: [-----]
[--] Week: [-----] +1,184
[--] Month: [-----] +505
[--] Months: [-----] +742
[--] Year: [-----] +1,020
1-Year High: [-----] on 2026-02-06
1-Year Low: [--] on 2025-12-28

Galaxy Score: [--]

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] [---]
1-Year High: [--] on 2026-01-13
1-Year Low: [--] on 2026-01-16

Engagements: [-----] (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [-----]
[--] Week: [-----] -74%
[--] Month: [------] +19%
[--] Months: [-------] +57%
[--] Year: [-------] -4.50%
1-Year High: [------] on 2025-11-25
1-Year Low: [--] on 2025-09-14

Engagements by network (24h): News: [--] Reddit: [--] TikTok: [--] X: [---] YouTube: [--]

Mentions: [--] (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [--] +9.10%
[--] Month: [---] +76%
[--] Months: [-----] +23%
[--] Year: [-----] +172%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-09-14

Mentions by network (24h): News: [--] Reddit: [--] TikTok: [--] X: [--] YouTube: [--]

Creators: [--] (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Arcus Biosciences, Inc. (RCUS) in the last [--] hours which is up 29% from [--] in the previous [--] hours Daily Average: [--]
[--] Week: [--] +9.40%
[--] Month: [---] +31%
[--] Months: [---] -38%
[--] Year: [-----] +201%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-09-14

Sentiment: 75%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: 75%
Daily Average: 75%
[--] Week: 100% +50%
[--] Month: 50% +22%
[--] Months: 50% -38%
[--] Year: 50% -50%
1-Year High: 100% on 2025-02-15
1-Year Low: 3% on 2025-12-07

Most Supportive Themes:

  • Positive Social Media Trends: (75%) Social dominance, Galaxy Score, and sentiment have all seen significant increases, indicating growing positive attention and engagement.
  • Increased Content Creation: (25%) The number of posts about Arcus Biosciences has risen over the past [--] months and [--] year, suggesting sustained interest.

Most Critical Themes:

  • Discontinuation of STAR-221 Study: (60%) The Phase [--] STAR-221 study has been discontinued, raising concerns about TIGIT therapy efficacy.
  • Analyst Downgrades: (40%) Arcus Biosciences (RCUS) was among the stocks that received downgrades on February 12th, contributing to negative price action.

Social Dominance: 0.00225%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00225%
Daily Average: 0.00474%
[--] Week: 0.0089% +0.0085%
[--] Month: 0.0031% -0.0012%
[--] Months: 0.0031% -0.0056%
[--] Year: 0.0031% -0.001%
1-Year High: 0.032% on 2025-06-28
1-Year Low: 0.0002% on 2025-09-14

Market Dominance: 0.00265%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00265%
Daily Average: 0%
1-Year High: 0.12% on 2026-02-06
1-Year Low: 0.00265% on 2026-02-14

Market Cap: $2,340,943,901

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $2,340,943,901
Daily Average: $2,795,082,619
[--] Week: $2,338,469,330 -10%
[--] Month: $2,340,943,901 -13%
1-Year High: $3,229,314,790 on 2025-11-28
1-Year Low: $2,340,943,901 on 2026-02-13

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

Arcus Biosciences, Inc. (RCUS)
/topic/$rcus